Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3017% above fair value
$367.13−1.75 (-0.47%)
Close on Nov 20, 2026Market cap $29.81BP/E 30.1Yield 0.78%
Labcorp net income
Net income is the profit left for shareholders after every expense, interest and tax.
Labcorp's net income for the twelve months ending Sep 30, 2026 was $1.00B, up 17.4% year over year. For fiscal 2025 it was $876.50M, up 17.5% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $2.38B in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $876.50M | +17.5% |
| FY2024 | Dec 31, 2024 | $746.00M | +78.5% |
| FY2023 | Dec 31, 2023 | $418.00M | -67.3% |
| FY2022 | Dec 31, 2022 | $1.28B | -46.2% |
| FY2021 | Dec 31, 2021 | $2.38B | +52.8% |
| FY2020 | Dec 31, 2020 | $1.56B | +88.9% |
| FY2019 | Dec 31, 2019 | $823.80M | -6.8% |
| FY2018 | Dec 31, 2018 | $883.70M | -28.0% |
| FY2017 | Dec 31, 2017 | $1.23B | +72.4% |
| FY2016 | Dec 31, 2016 | $711.80M | +62.7% |
| FY2015 | Dec 31, 2015 | $437.60M | -14.4% |
| FY2014 | Dec 31, 2014 | $511.20M | -10.9% |
| FY2013 | Dec 31, 2013 | $573.80M | -1.6% |
| FY2012 | Dec 31, 2012 | $583.10M | +12.2% |
| FY2011 | Dec 31, 2011 | $519.70M | -6.9% |
| FY2010 | Dec 31, 2010 | $558.20M | +2.7% |
| FY2009 | Dec 31, 2009 | $543.30M | +17.0% |
| FY2008 | Dec 31, 2008 | $464.50M | -2.6% |
| FY2007 | Dec 31, 2007 | $476.80M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $262.80M | +0.7% |
| Q2 FY2026 | Jun 30, 2026 | $298.70M | +25.6% |
| Q1 FY2026 | Mar 31, 2026 | $277.80M | +30.5% |
| Q4 FY2025 | Dec 31, 2025 | $164.70M | +14.9% |
| Q3 FY2025 | Sep 30, 2025 | $261.10M | +54.2% |
| Q2 FY2025 | Jun 30, 2025 | $237.90M | +15.9% |
| Q1 FY2025 | Mar 31, 2025 | $212.80M | -6.7% |
| Q4 FY2024 | Dec 31, 2024 | $143.40M | – |
| Q3 FY2024 | Sep 30, 2024 | $169.30M | -7.6% |
| Q2 FY2024 | Jun 30, 2024 | $205.30M | +8.7% |
| Q1 FY2024 | Mar 31, 2024 | $228.00M | +7.1% |
| Q4 FY2023 | Dec 31, 2023 | -$167.10M | -319.6% |
| Q3 FY2023 | Sep 30, 2023 | $183.30M | -48.0% |
| Q2 FY2023 | Jun 30, 2023 | $188.90M | -47.3% |
| Q1 FY2023 | Mar 31, 2023 | $212.90M | -56.7% |
| Q4 FY2022 | Dec 31, 2022 | $76.10M | -86.2% |
| Q3 FY2022 | Sep 30, 2022 | $352.80M | -39.9% |
| Q2 FY2022 | Jun 30, 2022 | $358.60M | -23.3% |
| Q1 FY2022 | Mar 31, 2022 | $491.60M | -36.1% |
| Q4 FY2021 | Dec 31, 2021 | $553.00M | -41.1% |
| Q3 FY2021 | Sep 30, 2021 | $587.30M | -16.5% |
| Q2 FY2021 | Jun 30, 2021 | $467.40M | +101.8% |
| Q1 FY2021 | Mar 31, 2021 | $769.60M | – |
| Q4 FY2020 | Dec 31, 2020 | $938.30M | +313.2% |
| Q3 FY2020 | Sep 30, 2020 | $703.40M | – |
| Q2 FY2020 | Jun 30, 2020 | $231.60M | +21.6% |
| Q1 FY2020 | Mar 31, 2020 | -$317.20M | -270.9% |
| Q4 FY2019 | Dec 31, 2019 | $227.10M | +43.8% |
| Q3 FY2019 | Sep 30, 2019 | -$317.20M | -199.5% |
| Q2 FY2019 | Jun 30, 2019 | $190.40M | -18.6% |
| Q1 FY2019 | Mar 31, 2019 | $185.60M | +7.2% |
| Q4 FY2018 | Dec 31, 2018 | $157.90M | -77.0% |
| Q3 FY2018 | Sep 30, 2018 | $318.80M | +85.9% |
| Q2 FY2018 | Jun 30, 2018 | $233.80M | +26.5% |
| Q1 FY2018 | Mar 31, 2018 | $173.20M | -5.4% |
| Q4 FY2017 | Dec 31, 2017 | $687.80M | +273.0% |
| Q3 FY2017 | Sep 30, 2017 | $171.50M | – |
| Q2 FY2017 | Jun 30, 2017 | $184.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $183.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $184.40M | – |
See a number that looks wrong?